The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer

The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a highly aggressive subtype of BC. A pathological complete response (pCR) to neoadjuvant chemotherapy is strongly associated with a favorable TNBC prognosis; however, established predictors of pCR, including tumor-infiltrating lymphocytes (TILs), are often not...

Full description

Saved in:
Bibliographic Details
Main Authors: Chikako Funasaka, Takahiro Kogawa, Naoya Sakamoto, Shota Kusuhara, Takehiro Nakao, Hiromichi Nakajima, Chihiro Kondoh, Kenichi Harano, Nobuaki Matsubara, Ako Hosono, Yoichi Naito, Mototsugu Shimokawa, Rurina Watanuki, Yuji Yamashita, Chisako Yamauchi, Tatsuya Onishi, Genichiro Ishii, Toru Mukohara
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Triple-negative breast cancer
TIL
neoadjuvant chemotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294225000772
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2468294225000772

Similar Items